Sonay İncesoy Özdemİr1, Nurdan Taçyıldız2, Alİ Varan3, Rejİn Kebudi4, Osman Bülent Zülfikar4, Tülin Tiraje Celkan5, Gürses Şahin6, Funda Vesile Çorapcıoğlu7, Zuhal Keskin Yıldırım8, Faruk Güçlü Pınarlı1,9, Hatice Nur Olgun10, Neriman Sarı11, Ayhan Dağdemir12, Derya Özyörük13, Tuba Eren14, Fatma Betül Çakır15, Başak Adaklı Aksoy16, Ceyhun Bozkurt17, Elif Güler18, Ali Aykan Özgüven19, Mehmet Fatih Erbey20, Melda Berber Hamamci2, Handan Dinçaslan2, Emel Ünal2, Mehmet Kantar21. 1. Department of Pediatric Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey 2. Department of Pediatric Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey 3. Department of Pediatric Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey 4. Institute of Oncology, İstanbul University, İstanbul, Turkey 5. Department of Pediatric Hematology Oncology, Faculty of Medicine, İstanbul University, İstanbul, Turke 6. Department of Pediatric Oncology, Dr. Sami Ulus Children’s Hospital, Ankara, Turkey 7. Department of Pediatric Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey 8. Department of Pediatric Oncology, Faculty of Medicine, Atatürk University, Erzurum, Turkey 9. Department of Pediatric Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey 10. Department of Pediatric Oncology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey 11. Department of Pediatric Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey 12. Department of Pediatric Oncology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey 13. Department of Pediatric Oncology, Ankara Children’s Hematology and Oncology Training and Research Hospital, Ankara, Turkey 14. Department of Pediatric Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey 15. Department of Pediatric Hematology Oncology, Faculty of Medicine, Bezmiâlem Vakıf University, İstanbul, Turkey 16. Department of Pediatric Hematology Oncology, Faculty of Medicine, Medeniyet University, İstanbul, Turkey 17. Department of Pediatric Hematology Oncology, Faculty of Medicine, Istinye University, Bahçelievler Medikal Park Hospital, İstanbul, Turkey 18. Department of Pediatric Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey 19. Department of Pediatric Oncology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey 20. Department of Pediatric Hematology Oncology, Faculty of Medicine, Koç University, Ankara, Turkey 21. Department of Pediatric Oncology, Faculty of Medicine, Ege University, İzmir, Turkey
Abstract
Aim: The main purpose of this study is to determine the current status of long-term follow-up (LTFU) for childhood cancer survivors and the challenges of LTFU for pediatric cancer survivors at pediatric oncology institutions in Turkey. Material and methods: A questionnaire was e-mailed to the directors of 33 pediatric oncology centers (POCs) registered in the Turkish Pediatric Oncology Group (TPOG). Of these 33 active TPOG institutions, 21 participated in the study and returned their completed questionnaires. Results: Only 1 of the 21 participating centers had a separate LTFU clinic. The remaining centers provided LTFU care for childhood cancer survivors at the pediatric oncology outpatient clinic. Of these centers, 17 (80.9%) reported difficulty in transition from the pediatric clinic to the adult clinic, 14 (66.6%) reported insufficient care providers, and 12 (57.1%) reported insufficient time and transportation problems. As neglected late effects, 16 (76.1%) centers reported psychosocial and getty job problems and 11 (52.3%) reported sexual and cognitive problems. None of the centers had their own LTFU guidelines for their daily LTFU practice Conclusion: This study was the first to gain an overview of the needs of POCs and the gaps in survivorship services in Turkey. The results from this study will help to develop a national health care system and national guidelines for pediatric cancer survivors. This work is licensed under a Creative Commons Attribution 4.0 International License.
Aim: The main purpose of this study is to determine the current status of long-term follow-up (LTFU) for childhood cancer survivors and the challenges of LTFU for pediatric cancer survivors at pediatric oncology institutions in Turkey. Material and methods: A questionnaire was e-mailed to the directors of 33 pediatric oncology centers (POCs) registered in the Turkish Pediatric Oncology Group (TPOG). Of these 33 active TPOG institutions, 21 participated in the study and returned their completed questionnaires. Results: Only 1 of the 21 participating centers had a separate LTFU clinic. The remaining centers provided LTFU care for childhood cancer survivors at the pediatric oncology outpatient clinic. Of these centers, 17 (80.9%) reported difficulty in transition from the pediatric clinic to the adult clinic, 14 (66.6%) reported insufficient care providers, and 12 (57.1%) reported insufficient time and transportation problems. As neglected late effects, 16 (76.1%) centers reported psychosocial and getty job problems and 11 (52.3%) reported sexual and cognitive problems. None of the centers had their own LTFU guidelines for their daily LTFU practice Conclusion: This study was the first to gain an overview of the needs of POCs and the gaps in survivorship services in Turkey. The results from this study will help to develop a national health care system and national guidelines for pediatric cancer survivors. This work is licensed under a Creative Commons Attribution 4.0 International License.
Entities:
Keywords:
Long term follow-up; Turkey; pediatric oncology; survivorship
Authors: Gregory T Armstrong; Toana Kawashima; Wendy Leisenring; Kayla Stratton; Marilyn Stovall; Melissa M Hudson; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2014-03-17 Impact factor: 44.544
Authors: Lisa B Kenney; Patrice Melvin; Laurie N Fishman; Joanne O'Sullivan-Oliveira; Gregory S Sawicki; Sonja Ziniel; Lisa Diller; Susan M Fernandes Journal: Pediatr Blood Cancer Date: 2016-07-27 Impact factor: 3.167
Authors: Daniel C Bowers; Soumya Adhikari; Yasmin M El-Khashab; Lynn Gargan; Kevin C Oeffinger Journal: Pediatr Blood Cancer Date: 2009-12-15 Impact factor: 3.167
Authors: Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison Journal: N Engl J Med Date: 2006-10-12 Impact factor: 176.079